Association between precystectomy epithelial tumor marker response to neoadjuvant chemotherapy and oncological outcomes in urothelial bladder cancer

Tumor Marker ◽

Epithelial Tumor ◽

Oncological Outcomes ◽

Urothelial Bladder ◽

MP06-05 PRECYSTECTOMY EPITHELIAL TUMOR MARKER RESPONSE TO NEOADJUVANT CHEMOTHERAPY AND ITS EFFECT ON ONCOLOGICAL OUTCOMES IN UROTHELIAL BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2016.02.2166 ◽

2016 ◽

Vol 195 (4S) ◽

Author(s):

Soroush T Bazargani ◽

Thomas G. Clifford ◽

Hooman Djaladat ◽

Anne Schuckman ◽

Sarmad Sadeghi ◽

...

Keyword(s):

Bladder Cancer ◽

Tumor Marker ◽

Epithelial Tumor ◽

Oncological Outcomes ◽

Urothelial Bladder ◽

405 Urothelial bladder cancer: Bcl-2 is upregulated in lymph node metastases and a marker of unfavourable response to neoadjuvant chemotherapy

European Urology Supplements ◽

10.1016/s1569-9056(14)60400-0 ◽

2014 ◽

Vol 13 (1) ◽

pp. e405

Author(s):

V. Skuginna ◽

B. Kiss ◽

A. Fleischmann ◽

G.N. Thalmann ◽

R. Seiler

Keyword(s):

Bladder Cancer ◽

Lymph Node ◽

Lymph Node Metastases ◽

Urothelial Bladder ◽

Node Metastases ◽

Role of Inflammation in the Perioperative Management of Urothelial Bladder Cancer With Squamous-Cell Features: Impact of Neutrophil-to-Lymphocyte Ratio on Outcomes and Response to Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2017.01.024 ◽

2017 ◽

Vol 15 (4) ◽

pp. e697-e706 ◽

Cited By ~ 9

Author(s):

Oscar Buisan ◽

Anna Orsola ◽

Mario Oliveira ◽

Roberto Martinez ◽

Olatz Etxaniz ◽

...

Keyword(s):

Bladder Cancer ◽

Squamous Cell ◽

Perioperative Management ◽

Neutrophil To Lymphocyte Ratio ◽

Lymphocyte Ratio ◽

Urothelial Bladder ◽

MP47-06 IMPACT OF VARIANT HISTOLOGY ON RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR UROTHELIAL BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2018.02.1485 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Michael Lin-Brande ◽

Daniel Zainfeld ◽

Saum Ghodoussipour ◽

Jie Cai ◽

Gus Miranda ◽

...

Keyword(s):

Bladder Cancer ◽

Urothelial Bladder ◽

Variant Histology ◽

MP78-11 ONCOLOGICAL OUTCOMES WITH NEOADJUVANT CHEMOTHERAPY AND CYSTECTOMY FOR MALE PATIENTS WITH CT4A UROTHELIAL BLADDER CANCER

The Journal of Urology ◽

10.1016/j.juro.2018.02.2559 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Jian Chen ◽

Gus Miranda ◽

Jie Cai ◽

Siamak Daneshmand ◽

Hooman Djaladat

Keyword(s):

Bladder Cancer ◽

Oncological Outcomes ◽

Urothelial Bladder ◽

Male Patients

Association between epithelial tumor markers’ trends during the course of treatment and oncological outcomes in urothelial bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2017.06.011 ◽

2017 ◽

Vol 35 (10) ◽

pp. 609-611 ◽

Cited By ~ 1

Author(s):

Soroush T. Bazargani ◽

Thomas Clifford ◽

Hooman Djaladat ◽

Anne Schuckman ◽

Sarmad Sadeghi ◽

...

Keyword(s):

Bladder Cancer ◽

Tumor Markers ◽

Epithelial Tumor ◽

Oncological Outcomes ◽

Urothelial Bladder

Systemic inflammatory markers and oncological outcomes in patients with high risk non-muscle invasive urothelial bladder cancer

European Urology Supplements ◽

10.1016/s1569-9056(18)33378-5 ◽

2018 ◽

Vol 17 (8) ◽

pp. 355

Author(s):

F. Cantiello ◽

G. Russo ◽

M. Vartolomei ◽

G. Musi ◽

G. Lucarelli ◽

...

Keyword(s):

Bladder Cancer ◽

High Risk ◽

Inflammatory Markers ◽

Oncological Outcomes ◽

Urothelial Bladder ◽

Muscle Invasive

Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial

BJU International ◽

10.1111/j.1464-410x.2009.09166.x ◽

2010 ◽

Vol 106 (4) ◽

pp. 493-499 ◽

Cited By ~ 47

Author(s):

Christian Bolenz ◽

Edwin Herrmann ◽

Patrick J. Bastian ◽

Maurice S. Michel ◽

Christian Wülfing ◽

...

Keyword(s):

Bladder Cancer ◽

Lymph Node ◽

Radical Cystectomy ◽

Lymphovascular Invasion ◽

Independent Predictor ◽

Node Negative ◽

Oncological Outcomes ◽

Urothelial Bladder

Neoadjuvant chemotherapy in urothelial bladder cancer: impact of regimen and variant histology

Future Oncology ◽

10.2217/fon-2016-0056 ◽

2016 ◽

Vol 12 (15) ◽

pp. 1795-1804 ◽

Cited By ~ 2

Author(s):

Hristos Z Kaimakliotis ◽

M Francesca Monn ◽

Jane S Cho ◽

Jose A Pedrosa ◽

Noah M Hahn ◽

...

Keyword(s):

Bladder Cancer ◽

Urothelial Bladder ◽

Variant Histology

Pathologic down-staging following standard (SD) MVAC (methotrexate-vinblastine-doxorubicine-cisplatin) or dose-dense MVAC (DD) neoadjuvant chemotherapy (NC) for muscle-invasive urothelial bladder cancer (UC): A retrospective multicenter cohort of the French Genitourinary Tumor Group (GETUG/AFU).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.4550 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 4550-4550 ◽

Cited By ~ 1

Author(s):

Damien Pouessel ◽

Sylvie Chevret ◽

Emmanuelle Bompas ◽

Laurys Boudin ◽

Charlotte Joly ◽

...

Keyword(s):

Bladder Cancer ◽

Multicenter Cohort ◽

Tumor Group ◽

Urothelial Bladder ◽

Muscle Invasive ◽

Dose Dense